Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marc Barthold"'
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170499 (2017)
Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on liver transplant waiting-lists.818 consecutive patients on the liver transplant waiting-list included to calculate the MELD, MESO Index, MELD-Na, UKEL
Externí odkaz:
https://doaj.org/article/50d50cf3a7ac439c96c2eb4d7e628965
Autor:
Harald Schrem, Valentin Schneider, Marlene Kurok, Alon Goldis, Maren Dreier, Alexander Kaltenborn, Wilfried Gwinner, Marc Barthold, Jan Liebeneiner, Markus Winny, Jürgen Klempnauer, Moritz Kleine
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0158732 (2016)
The aim of this study is to identify independent pre-transplant cancer risk factors after kidney transplantation and to assess the utility of G-chart analysis for clinical process control. This may contribute to the improvement of cancer surveillance
Externí odkaz:
https://doaj.org/article/519f7ebd710a4d3ca558bf342e2818ae
Autor:
Jochen Meyburg, Krassimira Alexandrova, Marc Barthold, Sabine Kafert-Kasting, Andrea S. Schneider, Masoumeh Attaran, Friederike Hoerster, Jan Schmidt, Georg F. Hoffmann, Michael Ott
Publikováno v:
Cell Transplantation, Vol 18 (2009)
Liver cell transplantation (LCT) is a very promising method for the use in pediatric patients. It is significantly less invasive than whole organ transplantation, but has the potential to cure or at least to substantially improve severe disorders lik
Externí odkaz:
https://doaj.org/article/b0c4c294b0c4488c99b0801c39eab797
Autor:
Krassimira Alexandrova, Carsten Griesel, Marc Barthold, Hans-Gert Heuft, Michael Ott, Michael Winkler, Harald Schrem, Michael P. Manns, Timm Bredehornsp, Marc Net, Martí Manyalich I Vidal, Sabine Kafert-Kasting, Lubomir Arseniev
Publikováno v:
Cell Transplantation, Vol 14 (2005)
During the last decade, hepatocyte transplantation has been suggested as a safe and potentially effective clinical option for the treatment of acute or decompensating chronic liver failure as well as for hereditary liver disease. Currently, one of th
Externí odkaz:
https://doaj.org/article/60956229ff9a48a584fb7ce42b0d056a
Autor:
Wilfried Gwinner, Alon Goldis, Harald Schrem, Marlene Kurok, Maren Dreier, Moritz Kleine, Valentin Schneider, Alexander Kaltenborn, Marc Barthold, Markus Winny, Jan Liebeneiner, Jürgen Klempnauer
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 7, p e0158732 (2016)
PLoS ONE, Vol 11, Iss 7, p e0158732 (2016)
Background The aim of this study is to identify independent pre-transplant cancer risk factors after kidney transplantation and to assess the utility of G-chart analysis for clinical process control. This may contribute to the improvement of cancer s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975d2a10d4ecc7d07518448532a62f87
https://pubmed.ncbi.nlm.nih.gov/27398803
https://pubmed.ncbi.nlm.nih.gov/27398803
Publikováno v:
PUB-Publications at Bielefeld University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::96080d80c09385f075ad3fd9aad20bb9
https://pub.uni-bielefeld.de/record/2959350
https://pub.uni-bielefeld.de/record/2959350
Autor:
Marc Barthold, Sabine Tischer, Lubomir Arseniev, Lilia Goudeva, Britta Maecker-Kolhoff, Rainer Blasczyk, Krasimira Aleksandrova, Wolfgang Mende, Britta Eiz-Vesper, Stephan Kloeß, Ulrike Koehl, Christoph Priesner, Hans-Gert Heuft
Publikováno v:
Journal of Translational Medicine
Background The adoptive transfer of allogeneic antiviral T lymphocytes derived from seropositive donors can safely and effectively reduce or prevent the clinical manifestation of viral infections or reactivations in immunocompromised recipients after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a81fec9402a812b14f7b50451330ca1
http://europepmc.org/articles/PMC4335407
http://europepmc.org/articles/PMC4335407
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170499 (2017)
PLoS ONE
PLoS ONE
Background Model of end-stage liver disease (MELD)-score and diverse variants are widely used for prognosis on liver transplant waiting-lists. Methods 818 consecutive patients on the liver transplant waiting-list included to calculate the MELD, MESO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f875a9479a5b80a2516a7b59375725
https://doi.org/10.1371/journal.pone.0170499
https://doi.org/10.1371/journal.pone.0170499
Autor:
Christian Krauth, Marc Barthold, Jürgen Klempnauer, Alexander Kaltenborn, B. Reichert, Volker Amelung, Felix Braun, Courtney Metz, Armin Koch, Anna-Luise Platsakis, Harald Schrem, Thomas Becker
Publikováno v:
Langenbeck's archives of surgery. 399(8)
The MELD-score was shown to be able to predict 90-day mortality in most patients with end-stage liver disease prior to liver transplantation and is used as a widely accepted measure for transplantation urgency. Prognostic ability of the BAR-score to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0752aa4501457ab695f2666aa48165a6
https://pubmed.ncbi.nlm.nih.gov/25218679
https://pubmed.ncbi.nlm.nih.gov/25218679
Autor:
Martí Manyalich I Vidal, Marc Barthold, Hans-Gert Heuft, Carsten Griesel, Michael Winkler, Marc Net, Lubomir Arseniev, Harald Schrem, Timm Bredehorn, Michael P. Manns, Michael Ott, Krassimira Alexandrova, Sabine Kafert-Kasting
Publikováno v:
Cell Transplantation, Vol 14 (2005)
During the last decade, hepatocyte transplantation has been suggested as a safe and potentially effective clinical option for the treatment of acute or decompensating chronic liver failure as well as for hereditary liver disease. Currently, one of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d2c05903dd2b0f7e61c2734d6f6d1c6
https://doaj.org/article/60956229ff9a48a584fb7ce42b0d056a
https://doaj.org/article/60956229ff9a48a584fb7ce42b0d056a